Scope Laboratories Private Limited

Scope Laboratories Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials and compliance.
CIN U24233KA1995PTC018302 Incorporated 14 July 1995 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2022
₹18,560
▼ 69.00% YoY
EBITDA · FY 2022
*****
▼ 69.00% YoY
Net profit · FY 2022
*****
▼ 69.00% YoY
Authorised capital
₹34.99 Lakh
Registered with MCA
Paid-up capital
₹34.99 Lakh
Issued & subscribed
Open charges
None
Satisfied ₹8.75 Cr
Company age
31 yrs
Est. 1995
Last financials
Mar 2022
Balance sheet date

About Scope Laboratories Private Limited

Data last updated: 03 February 2026

Scope Laboratories Private Limited is a private limited company based in Bangalore, Karnataka, India. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 14 July 1995, the company has been in operation for over 31 years.

Registered with ROC Bangalore under CIN U24233KA1995PTC018302.

Capital: an authorised share capital of ₹34.99 Lakh and a paid-up capital of ₹34.99 Lakh. It is led by directors Kumar Amudha and Rajesh Manoharlal Talreja.

Last AGM: 29 April 2022. Financial statements filed for year ended 31 March 2022. Office: 3/2 – 3 Bellary Road Sadashivanagara Rmv Extention Aramane Nagar, Bangalore, Karnataka, India – 560080.

As per the financials filed for FY 2022, the company reported a revenue of ₹18,560, a decline of 69% compared to the previous year.

As per MCA filings, the company has satisfied charges of ₹8.75 Cr on record.

Company Details of Scope Laboratories Private Limited
CIN U24233KA1995PTC018302
Registration Number 018302
Incorporation Date 14 July 1995
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 April 2022
Date of Balance Sheet 31 March 2022
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    3/2 – 3 Bellary Road Sadashivanagara Rmv Extention Aramane Nagar, Bangalore, Karnataka, India – 560080
  • Industry
    Pharma, Pharma Contract R&D
Company report
Scope Laboratories Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Scope Laboratories Private Limited report

Financials, compliance, directors, charges, ownership and filings for Scope Laboratories Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Scope Laboratories Private Limited

Scope Laboratories Private Limited has one previous CIN (Corporate Identification Number): U02423KA1995PTC018302. The current CIN is U24233KA1995PTC018302, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24233KA1995PTC018302 Current
U02423KA1995PTC018302 Previous

Business Activity of Scope Laboratories Private Limited

Scope Laboratories Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Scope Laboratories Private Limited

Scope Laboratories Private Limited is audited by NARASIMHACHARCHAYANATHARAMACHANDRASHARMA for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
NARASIMHACHARCHAYANATHARAMACHANDRASHARMA blur-value blur-value blur-value

Board of Directors of Scope Laboratories Private Limited

Scope Laboratories Private Limited is currently managed by 2 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Kumar Amudha Director 25 Jan 2021 5 Years 5 Months Current
Rajesh Manoharlal Talreja Director 25 Jan 2021 5 Years 5 Months Current

Financials of Scope Laboratories Private Limited FY 2022 filings available

Scope Laboratories Private Limited reported revenue of ₹18,560 (down 69% YoY) for FY 2022. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹18,560 ▼ -69%
Profit
***** ▼ -69%
EBITDA
***** ▼ -69%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Scope Laboratories Private Limited

As of FY 2022, Scope Laboratories Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings of Scope Laboratories Private Limited

Open charges
₹0
Satisfied charges
₹8.75 Cr
Breakdown by lending institutions
Axis Bank Ltd₹5.50 Cr
Indian Bank₹3.25 Cr
Latest charge details
DateLenderAmountStatus
18 Dec 2007 Axis Bank Ltd ₹5.5 Cr Satisfied
03 Apr 2007 Indian Bank ₹3.25 Cr Satisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Scope Laboratories Private Limited

View historical data on people associated with Scope Laboratories Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Scope Laboratories Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Scope Laboratories Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Scope Laboratories Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Scope Laboratories Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Scope Laboratories Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Scope Laboratories Private Limited

MSME Payment Delays by Scope Laboratories Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Scope Laboratories Private Limited

Subsidiaries & Group Companies of Scope Laboratories Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Scope Laboratories Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Scope Laboratories Private Limited

MCA Filings & Documents of Scope Laboratories Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Scope Laboratories Private Limited

Activity
29 Apr 2022
Scope Laboratories Private Limited last Annual general meeting of members was held on 29 Apr 2022 as per latest MCA records.
Activity
31 Mar 2022
Scope Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore.
Directors
25 Jan 2021
Kumar Amudha was appointed as a Director on 25 Jan 2021 & has been associated with this company since 5 years 5 months.
Directors
25 Jan 2021
Rajesh Manoharlal Talreja was appointed as a Director on 25 Jan 2021 & has been associated with this company since 5 years 5 months.
Charges
23 Dec 2013
A charge registered on 18 Dec 2007 via Charge ID 10085447 with Axis Bank Ltd was fully satisfied on 23 Dec 2013.
Charges
26 Oct 2013
A charge registered on 03 Apr 2007 via Charge ID 10046788 with Indian Bank was fully satisfied on 26 Oct 2013.

Frequently Asked Questions about Scope Laboratories Private Limited

Scope Laboratories Private Limited is an active private limited company in the pharma sector based in Bangalore, Karnataka, India. It was incorporated on 14 July 1995 (31+ years old) and is registered under CIN U24233KA1995PTC018302.

Scope Laboratories Private Limited reported revenue of ₹18,560 for FY 2022 (down 69.00% YoY).

The current directors of Scope Laboratories Private Limited are:

The primary industry of Scope Laboratories Private Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Scope Laboratories Private Limited can be reached at the registered office: 32 – 3 Bellary Road Sadashivanagara Rmv Extention Aramane Nagar, Bangalore, Karnataka, India – 560080.

The authorised capital is ₹34.99 Lakh, and the paid-up capital is ₹34.99 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available